116 related articles for article (PubMed ID: 25714282)
21. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging.
Schwartz LH; Panicek DM; Koutcher JA; Brown KT; Getrajdman GI; Heelan RT; Burt M
Radiology; 1995 Nov; 197(2):421-5. PubMed ID: 7480686
[TBL] [Abstract][Full Text] [Related]
22. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging.
Tsushima Y; Ishizaka H; Matsumoto M
Radiology; 1993 Mar; 186(3):705-9. PubMed ID: 8430178
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
24. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules.
Jhaveri KS; Wong F; Ghai S; Haider MA
AJR Am J Roentgenol; 2006 Nov; 187(5):1303-8. PubMed ID: 17056920
[TBL] [Abstract][Full Text] [Related]
25. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
26. MR evaluation of adrenal masses at 1.5 T.
Baker ME; Blinder R; Spritzer C; Leight GS; Herfkens RJ; Dunnick NR
AJR Am J Roentgenol; 1989 Aug; 153(2):307-12. PubMed ID: 2750617
[TBL] [Abstract][Full Text] [Related]
27. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
[TBL] [Abstract][Full Text] [Related]
28. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT.
Seo JM; Park BK; Park SY; Kim CK
AJR Am J Roentgenol; 2014 May; 202(5):1043-50. PubMed ID: 24758658
[TBL] [Abstract][Full Text] [Related]
29. Utility of chemical shift and diffusion-weighted imaging in characterization of hyperattenuating adrenal lesions at 3.0T.
Song J; Zhang C; Liu Q; Yu T; Jiang X; Xia Q; Zhang Y; Sequeiros RB
Eur J Radiol; 2012 Sep; 81(9):2137-43. PubMed ID: 22036592
[TBL] [Abstract][Full Text] [Related]
30. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT.
Sebro R; Aslam R; Muglia VF; Wang ZJ; Westphalen AC
Abdom Imaging; 2015 Feb; 40(2):318-26. PubMed ID: 25095753
[TBL] [Abstract][Full Text] [Related]
31. Proton-density fat fraction measurement: A viable quantitative biomarker for differentiating adrenal adenomas from nonadenomas.
Meng X; Chen X; Shen Y; Hu X; Tang H; Hu D; Li Z; Kamel IR
Eur J Radiol; 2017 Jan; 86():112-118. PubMed ID: 28027736
[TBL] [Abstract][Full Text] [Related]
32. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
33. Utility of diffusion-weighted MRI in characterization of adrenal lesions.
Miller FH; Wang Y; McCarthy RJ; Yaghmai V; Merrick L; Larson A; Berggruen S; Casalino DD; Nikolaidis P
AJR Am J Roentgenol; 2010 Feb; 194(2):W179-85. PubMed ID: 20093571
[TBL] [Abstract][Full Text] [Related]
34. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
35. Comparison of qualitative and quantitative evaluation of diffusion-weighted MRI and chemical-shift imaging in the differentiation of benign and malignant vertebral body fractures.
Geith T; Schmidt G; Biffar A; Dietrich O; Dürr HR; Reiser M; Baur-Melnyk A
AJR Am J Roentgenol; 2012 Nov; 199(5):1083-92. PubMed ID: 23096183
[TBL] [Abstract][Full Text] [Related]
36. [Turbo-spin-echo (TSE) sequences with selective fat suppression (SPIR) compared with chemical shift sequences in MRI for differentiation of adrenal tumors. Spectral Presaturation by Inversion Recovery].
Kreft B; Sommer T; Vahlensieck M; Seewald S; Vetter H; Schild H
Rofo; 1995 Apr; 162(4):311-8. PubMed ID: 7749086
[TBL] [Abstract][Full Text] [Related]
37. Adrenal lesions with heterogeneous suppression on chemical shift imaging: clinical implications.
Gabriel H; Pizzitola V; McComb EN; Wiley E; Miller FH
J Magn Reson Imaging; 2004 Mar; 19(3):308-16. PubMed ID: 14994299
[TBL] [Abstract][Full Text] [Related]
38. Differential diagnosis of adrenal masses by chemical shift and dynamic gadolinium enhanced MR imaging.
Sasai N; Togami I; Tsunoda M; Sei T; Akaki S; Hiraki Y
Acta Med Okayama; 2003 Aug; 57(4):163-70. PubMed ID: 14627067
[TBL] [Abstract][Full Text] [Related]
39. Characterization of adrenal masses with diffusion-weighted imaging.
Sandrasegaran K; Patel AA; Ramaswamy R; Samuel VP; Northcutt BG; Frank MS; Francis IR
AJR Am J Roentgenol; 2011 Jul; 197(1):132-8. PubMed ID: 21701021
[TBL] [Abstract][Full Text] [Related]
40. Characterization of adrenal lesions on chemical shift MRI: comparison of 1.5 T and 3 T MRI.
Hekimsoy İ; Güler E; Harman M; Elmas N
Abdom Radiol (NY); 2019 Oct; 44(10):3359-3369. PubMed ID: 31129784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
